Avricore Health (AVCRF) Receivables (2009 - 2025)

Avricore Health has disclosed Receivables across 17 years of filings, most recently posting $26770.3 for Q4 2025.

• In Q4 2025, Receivables fell 91.2% year-over-year to $26770.3; the TTM figure through Dec 2025 stood at $26770.3 (down 91.2% YoY), while the FY2025 annual figure was $26719.3, down 91.39% from the prior year.
• Receivables grew to $26770.3 in Q4 2025, from $15076.9 in the prior quarter.
• Over the last five years, Receivables for AVCRF reached as high as $583946.8 in Q4 2022 and fell as low as $1540.3 in Q4 2023.
• The 5-year median for Receivables is $119797.8 (2021), against an average of $169663.8.
• Annual changes were most pronounced in 2023 — Receivables slumped 99.74% — and 2024, when it jumped 19647.32%.
• A 5-year view of Receivables shows it stood at $78737.8 in 2021, then soared by 641.63% to $583946.8 in 2022, then plunged by 99.74% to $1540.3 in 2023, then soared by 19647.32% to $304172.2 in 2024, then plunged by 91.2% to $26770.3 in 2025.
• According to Business Quant data, Receivables over the past three periods registered $26770.3, $15076.9, and $29981.4 for Q4 2025, Q3 2025, and Q2 2025 respectively.